Fundraising Fox
Telegraph Hill Partners
Growth equitySan Francisco · Growth · 18 people tracked
Also known as TELEGRAPH HILL PARTNERS MANAGEMENT COMPANY LLC
Find your way into Telegraph Hill Partners
Sign up to see every warm intro you have to Telegraph Hill Partners
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Telegraph Hill Partners team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
Telegraph Hill Partners partners with private life science, medical device, and healthcare companies that have novel technologies, a solid customer base, and innovative management teams. The firm provides growth capital to high-quality companies seeking to build and expand their organizations, offering an experienced team focused on efficiently driving growth and profitability while preserving each company's vision and integrity.
Source: firm website, verified Sep 29, 2026.
Team · 18 people
from the firm's website & curated & public directories
What they invest in
from 37 of 65 portfolio companiesBiotech ×23Healthtech ×21Medical Devices ×14Deep Tech ×12AI & Machine Learning ×6Advanced Manufacturing ×5Digital Health ×5Enterprise Software ×4
HQs:United States×29United Kingdom×1
Who they back
founder profiles across 12 portfolio companiesFounding team size:solo founder×82 founders×4
Investments · 65 tracked
founders shown can be your intro pathBy year:2026 · 22024 · 22023 · 52022 · 12021 · 32020 · 12019 · 32018 · 22017 · 32016 · 12015 · 22007 · 127 dated
Advanced ManufacturingHollister, US
Lisa Hood(Executive Officer)inDamon Terrill(Executive Officer)Matthew Lowell(Executive Officer)inKen Gelhaus(Executive Officer)Stephen Gunstream(Executive Officer, Director)
BoardAlexander Vos(Director)
Cell Microsystems develops automated instruments for cellular and molecular workflows used in life science research, including oncology, stem cell biology, and regenerative medicine.
BiotechDeep TechHardwareMedical DevicesDurham, US
Scott McGinnis(President)inNancy Allbritton(Director)Yuli Wang(Director)Matthew Megaro(Director)Gary Pace(Executive Officer, Director)Christopher Sims(Executive Officer, Director)
Board seatDeval LashkariRob Capone· per SEC Form D
Co-investorsNC IDEA
etherFAX provides cloud-based secure document delivery and fax transmission for businesses handling sensitive information.
AI & Machine LearningCloud ComputingCybersecurityEnterprise SoftwareHealthtechSaaS
Paul Banco(Co-Founder and EVP of Federal Programs)inRob Cichielo(Co-Founder and Chief Technology Officer)inJay Volk(Chief Executive Officer)inEmil Sturniolo(Chief Security Officer)inAllison Kirsch(Chief Marketing Officer)in
Magstim develops neurotechnology and neurostimulation devices for healthcare providers and researchers, focusing on neuromodulation and neurophysiology applications.
Deep TechHardwareHealthtechMedical DevicesMental HealthSan Francisco, US
BoardThomas A. Raffin(Executive Officer, Director)J. Matthew Mackowski(Executive Officer, Director)
Quanterix (operating together with Akoya) develops biomarker measurement platforms that combine ultrasensitive blood/CSF liquid immunoassays with spatial tissue proteomics for research and clinical use in neurology, oncology, inflammation, cardiology and infectious disease.
BiotechDigital HealthMedical DevicesBillerica, US
Brian McKelligon(Executive Officer)Garry Nolan(Director)Matthew Winkler(Director)
BoardRob Hart(Executive Officer)inThomas Raffin(Director)in
Board seatRobert Shepler· per SEC Form D
Invisalert Solutions provides a patient safety platform using machine learning and AI to monitor and prevent adverse events such as falls, infections, and elopement across acute care, emergency departments, behavioral health, and long-term care facilities.
AI & Machine LearningEnterprise SoftwareHealthtechWest Chester, US
Pete Nagy(Executive Officer, Director)Mark Gold(Director)
BoardRegina Widdow(Director)
Board seatRob HartGary CurtisTom Raffin· per SEC Form D
Mosaic Biosciences is a biologics discovery company that advances biologic drug candidates from discovery through IND-enabling studies and clinical development, working with partners across multiple therapeutic modalities.
BiotechDeep TechBoulder, US
Marty (Martin) Stanton(Founder & former CEO)inEric Furfine(Chief Scientific Officer)inAlexei Kazantsev(Vice President Protein Design and Engineering)inTracey Mullen(Chief Strategy Officer)inScott Glaser(SVP, Biologics Discovery)inJean-Pierre Wery(Chief Executive Officer)in
Board seatJeanette WelshRob Capone· per SEC Form D
Co-investorsMorgenthaler
A biopharmaceutical company that discovers and develops medicines, building on immunology research to explore additional disease areas.
BiotechHealthtechMadison, US
Jigar Patel(Executive Officer, Director)in
Board seatDeval LashkariRob Hart· per SEC Form D
Panome Bio provides metabolomics, proteomics, and multi-omics integration workflows along with a computational platform that analyzes and integrates diverse biological data types.
AI & Machine LearningBiotechDeep TechHealthtechSaint Louis, US
Edward Weinstein(Executive Officer, Director)inTom Cohen(Executive Officer)in
BoardDavid Smoller(Director)inAlexander Herzick(Director)in
Board seatDeval LashkariRob Capone· per SEC Form D
Co-investorsBioGenerator VenturesCultivation Capital
Develops tools to formulate and manufacture nanoparticles used as medicines; acquired by Danaher in 2021.
BiotechVancouver
Euan Ramsay(Executive Officer)inJames Taylor(Founder)inAndrew Booth(Director)R. James Taylor(Executive Officer, Director)Joe Victor(Executive Officer, Director)Daniel Nixon(Director)
Board seatDeval Lashkari· per SEC Form D
Co-investorsBDC Industrial Innovation Venture FundInnovative Solutions CanadaPage One VenturesRising Tide5AM Ventures
Seattle, US
Ronald Seubert(Executive Officer, Director, Promoter)Evan Castiglia(Executive Officer)inJoseph Victor(Executive Officer, Director)Frank Witney(Director)Eric Kaldjian(Executive Officer)
Board seatRobert Shepler· per SEC Form D
Co-investors5AM VenturesArboretum VenturesF-Prime CapitalHealthQuest CapitalSofinnova Ventures
Agena Bioscience develops genetic testing panels and platforms for pharmacogenomic and oncology research, including tools that identify drug-metabolism gene variants.
BiotechHealthtechMedical Devices
BiotechSan Diego, US
Francois Ferre(Director)Magda Marquet(Director)Jorge Garces(Executive Officer)inGreg Hamilton(Executive Officer, Director)Carin Sandvik(Executive Officer)Jeffrey G. Black(Executive Officer)
Co-investorsBioBritAlly Bridge GroupVivo CapitalWuXi Healthcare Ventures
Develops tools for endovascular therapy; acquired by The Spectranetics Corporation in 2014.
Co-investorsCalifornia Technology VenturesQuestMark PartnersSaints CapitalPsilos Group
Argonaut Manufacturing Services provides contract manufacturing for life sciences and healthcare products, serving partners across the health and biotech industries with expertise in cGMP manufacturing, regulatory affairs, and operational scaling.
Advanced ManufacturingBiotechEnterprise SoftwareHealthtechSaaSBoston, US
Rick(CEO)
Carterra designs and manufactures flexible microfluidic manufacturing systems for the life sciences and biotech research markets.
BiotechDeep TechMedical DevicesNew MaterialsSan Diego, US
Mr. Eckman(Founder)
Co-investorsPasadena Angels
Dharmacon Reagents provides synthetic oligonucleotides, gene modulation, and gene editing solutions for functional genomics research, enabling researchers to study genetic networks and advance therapeutic discovery.
AI & Machine LearningBiotechDeep TechHealthtech
Co-investorsBoulder Ventures
DYNEX Technologies develops and manufactures automated ELISA and chemiluminescence microplate instruments for clinical and diagnostic laboratories.
HealthtechMedical Devices
Co-investorsAmpersand
Emerging Therapy Solutions provides comprehensive management solutions for cell and gene therapies and transplants to payers, self-insured employers, and secondary payers.
HealthtechInsurTechMedical Devices
David J. McLean
Co-investorsSaints CapitalWe Ventures
GrayHawk Health provides in-home and virtual medical care combined with individual health coaching for high-risk, older community members, coordinating clinical, social, and behavioral health needs.
Digital HealthHealthtechWellness & FitnessWayne, US
Andrew Henderson II(Executive Officer, Director)inRaymond Falci(Director)Marc Watkins(Director)Rob Hart(Director)in
Thomson manufactures laboratory consumables including filter vials, shake flasks, well plates, and chromatography columns for pharmaceutical, biotech, environmental, toxicology, and contract manufacturing sectors.
Advanced ManufacturingBiotechHealthtechMedical Devices
Melissa Ellis(Founder Emeritus)in
Kytopen develops non-viral gene delivery technology called Flowfect that combines fluid flow with electric fields to deliver payloads such as mRNA, DNA, and CRISPR Cas9 RNP into cells for high-throughput transfection.
BiotechDeep TechHardwareCambridge, US
Cullen Buie(Founder; Board Observer)inPaulo Garcia(Founder)inMichael Chiu(Chief Executive Officer)in
BoardPaxton Major(Director)inAnn DeWitt(Director)inPaul Wotton(Director)
Co-investorsBantam GroupHorizons VenturesMassVenturesSelvedge VentureTBD AngelsThe Engine Ventures+2 more
Global medical device company focused on surgical technologies for the treatment of spinal disorders
Co-investorsEscalate Capital PartnersKeensight Capital
Nivagen provides drug product development services, guiding pharmaceutical companies through the full lifecycle from concept to commercialization, including traditional NDAs, 505(b)(2)s, and complex generics.
Advanced ManufacturingBiotechDigital HealthHealthtechMedical DevicesCalifornia, US
Dr. Nirav Patel
Promptly is a patient experience and engagement software suite for specialty medical practices, offering tools to automate practice operations and appointment scheduling.
Digital HealthEnterprise SoftwareHealthtechSaaS
RevMedica develops smart surgical stapling and soft tissue management systems for minimally invasive and robotic procedures, designed to provide real-time intraoperative data and improve clinical decision-making for surgeons.
AI & Machine LearningHealthtechMedical DevicesMiddletown, US
Thomas Wenchell(Chief Executive Officer and Co-Founder)inC. Robert Satti(Director)
Co-investorsConnecticut Innovations
HealthtechMountain View, US
Paul Rhodes(Executive Officer, Director)Ray Martino(Director)Paul Grossman(Director)in
TrakCel develops technology solutions for clinical trial services and cell therapy supply chain management, including cold chain logistics and software platforms for advanced therapy deployment.
BiotechHealthtechLogistics & Supply ChainMedical DevicesSaaSWales, GB
Dr Matthew Lakelin(Head of Consultancy Services & Co-Founder)Ravi Nalliah(Chief Executive Officer)inDr Akshay Peer(Chief Product Officer)
Co-investorsCencora VenturesCerity Partners Ventures
Verogen provides NGS sequencing systems and reagent solutions for forensic and research laboratories, with offerings including the MiSeq FGx Sequencing System and flexible financing options like leasing, reagent rental programs, and bundled workflows.
BiotechData & InfrastructureDeep TechGovTechLegalTechMedical DevicesSan Diego, US
Co-investors1315 Capital
Developer of an intraosseous medicine technology platform; acquired by Teleflex in 2013.
Co-investorsTargeted Technology FundsTullis Health Investors
Welcony is a healthcare technology company that brings together four brands—Magstim, EGI, Technomed, and Neurosign—to make neurotechnology products including Transcranial Magnetic Stimulation (TMS), high-density EEG, neuromonitoring, and clinical neurophysiology accessories.
Deep TechHealthtechMedical Devices
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Aquaro HistologyArgonaut Manufacturing ServicesCommunity BioEmerging Therapy SolutionsAccuMetricsAcroMetrixAlthea TechnologiesAmbionApplied PrecisionAsuragenAurora DiscoveryConfirmaDynexETSExcellosFreedom InnovationsFrontier PsychiatryInterface Catheter SolutionsKinetikos MedicalLDR HoldingMedPricern6NEXUS BiosystemsNivagen PharmaceuticalsPneumRxSAGE LabsSwitchGear GenomicsThomsonWasatch Microfluidics
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Exits · 3
1 IPOs · 2 acquisitionsAlpha TeknovaNASDAQ: TKNOAkoya Biosciencesacq. by QuanterixVidacareacq. by Teleflex
Portfolio news
latest coverage across their companiesKytopen · finsmes.com · Apr 7, 2026
IPO stake values · per SEC filings
Value of this firm's stake in each portfolio company at its IPO price, from the prospectus principal-stockholder table.
| Company | Owned | IPO price | At IPO | Stake value |
|---|---|---|---|---|
| Alpha Teknova | 64.6% | $16.00 | Jun 2021 | $280.2M |
Source: SEC S-1 / 424B prospectus filings. Stake value = shares beneficially owned × the initial public offering price, as disclosed — a market value at IPO, not a return multiple (the firm's original cost is not disclosed).
Public market activity · per SEC filings
what is this? ⓘDisclosed stake · filed Feb 2016
Disclosed stake · filed Jan 2015
Disclosed stake · filed Feb 2014
7 insider ownership filings (Forms 3/4/5)
at Alpha Teknova, Inc. (TKNO)
Files 13F institutional holdings reports · latest Jan 2016
From the firm's own SEC EDGAR filings — stakes and insider roles in public companies, typically portfolio companies after an IPO. Not a portfolio list published by the firm.
Frequently asked questions
- How many investments has Telegraph Hill Partners made?
- Telegraph Hill Partners has 65 tracked investments, 3 of which have exited, including 3 dated in the last 24 months.
- What stage does Telegraph Hill Partners invest at?
- Telegraph Hill Partners invests at the Growth stage.
- What is Telegraph Hill Partners's typical check size?
- Telegraph Hill Partners typically writes checks of $2M – $8M.
- What sectors does Telegraph Hill Partners focus on?
- Telegraph Hill Partners focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is Telegraph Hill Partners located?
- Telegraph Hill Partners is headquartered in San Francisco, US.
- Does Telegraph Hill Partners lead rounds?
- Yes, Telegraph Hill Partners leads investment rounds.
- Who does Telegraph Hill Partners co-invest with?
- Telegraph Hill Partners most often shares deals with Saints Capital, 5AM Ventures, Arboretum Ventures, among 32 tracked co-investors.
Images
Co-investors · 1
5AM Ventures is a life science venture capital firm founded in 2002 that funds and builds next-generation life sciences companies, focusing on biopharmaceuticals, drug delivery technologies, and life science instruments.
Firms observed investing alongside Telegraph Hill Partners, from public investor directories. Shared companies are the overlap with Telegraph Hill Partners's recorded portfolio.
Similar investors
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests in technology companies from seed to growth stage. Since inception it has backed over 200 companies and raised more than $1.3 billion.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Capricorn Partners is a Belgium-based, partner-owned independent management company for alternative investment funds, investing in innovative companies across digital, health and clean technologies with an ESG focus.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Eight Roads Ventures is a venture capital firm that backs and partners with technology and healthcare companies.